Trials / Completed
CompletedNCT04178239
Chronic Fatigue in Sarcoidosis
Neuropsychobiological Fingerprints of Chronic Fatigue in Sarcoidosis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 31 (actual)
- Sponsor
- RWTH Aachen University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Background: Chronic fatigue (CF) is a prominent symptom in many sarcoidosis patients, affecting quality of life (QoL) and interfering with treatment. This study investigates neuropsychobiological mechanisms and markers of CF in sarcoidosis.
Detailed description
Patients with a histological diagnosis of sarcoidosis are included. The Multidimensional Fatigue Inventory (MFI) is used to define patients with and without CF. All patients are then characterized using several fatigue, depression, QoL and executive functioning questionnaires. Cognitive functioning and underlying neural correlates are assessed using an n-back task measuring working memory and (sustained) attention during functional magnetic resonance imaging (fMRI). Sarcoidosis disease activity is determined using lung function, laboratory parameters, and exercise capacity.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | fMRI, questionnaires, pneumologic diagnostics | fMRI neuropsychological questionnaires pneumologic diagnostics: blood samples, whole body plethysmography, walking test |
Timeline
- Start date
- 2017-03-10
- Primary completion
- 2018-02-02
- Completion
- 2018-02-02
- First posted
- 2019-11-26
- Last updated
- 2019-11-27
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT04178239. Inclusion in this directory is not an endorsement.